Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-06

Clinical Trial Update: Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for an investigational therapy from Secretome Therapeutics in heart failure with preserved ejection fraction (HFpEF) is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Secretome Therapeutics Investigational Product

Snippet

Sponsor: Secretome Therapeutics | Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF) | Phase 1 | Status: RECRUITING